409 filings
Page 7 of 21
8-K
uaw 8dz4m0rolr
3 Feb 16
Innoviva reports Fourth Quarter and Full Year 2015 Financial Results
12:00am
8-K
ej3degbf2808puiunsus
22 Jan 16
Departure of Directors or Certain Officers
12:00am
8-K
c6xj 741em2598hlrg
15 Jan 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
evigg2c
8 Jan 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
pw0hoxd
28 Oct 15
Theravance Reports Third Quarter 2015 Financial Results
12:00am
8-K
rjgj k8uq
27 Oct 15
Other Events
12:00am
8-K
t4tyt ty5ohhw1g4dmw
6 Oct 15
Other Events
12:00am
8-K
mjrmos3cuh5220nbr
29 Sep 15
Other Events
12:00am
8-K
jf8uv0je8gf ng
28 Sep 15
Regulation FD Disclosure
12:00am
8-K
ppuzl84sc lj
24 Sep 15
Other Events
12:00am
8-K
yhsgz3a
8 Sep 15
GSK and Theravance announce results from the SUMMIT COPD CV Survival Study
12:00am
8-K
anm181v lt8hzxxts
6 Aug 15
GSK receives approval for BREO® ELLIPTA® for the treatment of adults with asthma
12:00am
8-K
62c5k5s
29 Jul 15
Theravance Reports Second Quarter 2015 Financial Results
12:00am
8-K
27o5pkyj00wj37urc5n6
13 Jul 15
Theravance, Inc. Appoints Michael Faerm as Chief Business Officer
12:00am
8-K
32zre n5fs6kwohjd
1 Jul 15
Regulation FD Disclosure
12:00am
8-K
h3ekj27qo0xdcf4v
20 May 15
Can Dual Long-acting Bronchodilator Therapy Prevent Clinically Important Deteriorations In Chronic Obstructive
12:00am
8-K
j5i4mq818o63
18 May 15
Regulation FD Disclosure
12:00am
8-K
xguk7kc
6 May 15
Theravance Reports First Quarter 2015 Financial Results
12:00am
8-K
rf95 6j69ize
30 Apr 15
FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the US
12:00am
8-K
69m 57donkbmk
27 Apr 15
Submission of Matters to a Vote of Security Holders
12:00am